Mephar SPRL
Mephar reported total assets of 470,027 € at the end of the 2025 financial year (annual accounts filed with the NBB on 13 May 2026).
The score of Mephar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -7 % Total assets -16 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Mephar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −34,378 € | ||||
| Equity | 426,042 € | ||||
| Cash | 135,676 € | ||||
| EBITDA | −1,186 € | ||||
| Total assets | 470,027 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 May 2026
- Year ended 31 Dec 2024filed on 15 May 2025
- Year ended 31 Dec 2023filed on 12 Jun 2024
- Year ended 31 Dec 2022filed on 13 Jul 2023
- Year ended 31 Dec 2021filed on 25 May 2022
Mephar's financial analysis
- Solvency90.6%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Mephar
Mephar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0424.193.569
- VAT number
- BE0424193569
- Peppol
- Registered · 0208:0424193569 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 08 Jun 1983
- Registered office
- 9100 Sint-Niklaas
- Latest accounts
- 2025 · filed on 13 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Mephar (SPRL) has been based in Sint-Niklaas since 1983, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 34,378 € and equity of 426,042 €; its revenue is not published. Its solvency stands at 90.6%, above the median of its sector (44.2%).
Companies similar to Mephar
Companies in the same business, of comparable size and area, outside its group.
- MV Pharma Retail sale of pharmaceutical products Saint-Ghislain · balance sheet 469,186 €
- Viesville Pharma Retail sale of pharmaceutical products Pont-à-Celles · balance sheet 470,253 €
- Apotheek Nossegem Retail sale of pharmaceutical products Zaventem · balance sheet 470,305 €
- Jely Pharma Retail sale of pharmaceutical products Incourt · balance sheet 469,684 €
- PharmaConseil Retail sale of pharmaceutical products Verviers · balance sheet 468,687 €
- Pharmacie DU Petit Moulin Retail sale of pharmaceutical products Seneffe · balance sheet 471,907 €
- Vipharma Retail sale of pharmaceutical products Saint-Ghislain · balance sheet 467,095 €
- Hermelize Retail sale of pharmaceutical products Dilbeek · balance sheet 473,074 €
Frequently asked questions about Mephar
What is the revenue of Mephar?
Mephar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Mephar?
In Belgium, the VAT number is the company number prefixed with BE: BE0424193569 for Mephar, if the company is VAT-registered. Its company number (CBE) is 0424.193.569.
Where is the registered office of Mephar?
According to the CBE register, the registered office of Mephar is in 9100 Sint-Niklaas.
What is the equity of Mephar?
At the close of the 2025 financial year, the equity of Mephar amounts to 426,042 €, a solvency of 90.6% of total assets.
Who manages Mephar?
The register lists 1 active mandates at Mephar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Mephar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →